xCELLigence RTCA HT-BioTek BioSpa8 – Screening Model
xCELLigence Real-Time Cell Analysis uses impedance-based biosensors to obtain non-invasive, label-free measurements, continuously monitoring cell health, behavior, and function with high accuracy, sensitivity, and reproducibility. Integrating the BioSpa 8 Automated Incubator with the xCELLigence RTCA HT model enables live cell analysis of up to eight 384-well E-plates (a total of 3,072 wells) to meet high throughput sample screening needs.
- RTCA Analyzers
Request a Quote
Product Details
- The xCELLigence RTCA HT instrument with BioTek BioSpa 8 automated incubator enables live cell analysis up to eight 384-well E-plates (a total of 3,072 wells) with non-invasive and label-free real-time impedance technology.
- Kinetic measurement of cell health, viability, or response to treatments with high sensitivity, accuracy, and reproducibility, provides a continuous flow of real-time data. The information gained from real-time live cell analysis goes far beyond end-point measurements.
- Automated workflow allows users to simply add cells to E-Plates 384 and begin kinetic measurements at physiological conditions. The BioSpa8 Robotic Arm transfers E-Plate 384 from the incubator to the xCELLigence RTCA HT Station. Multiple E-Plates 384 are processed while unattended, saving time in the lab.
- Critical physiological conditions are controlled and maintained in the BioSpa8 incubator to ensure assay success. Temperature and CO2/O2 control, plus humidity monitoring in the BioSpa facilitate live cell processes, and the cradle of the RTCA HT unit is temperature-controlled, for minimal disruption of the cells. The software continuously records environmental conditions.
- Small footprint saves benchtop space
- User-friendly RTCA software Pro HT-BioSpa enables simple assay setup (scheduling) for both single and multiple users, real-time data visualization, and powerful data analysis.
- Ideal for high throughput screening of therapeutic antibodies, drug compounds, and cytotoxicity.
- Typical applications include Compound-mediated cytotoxicity assay; Viral-mediated cytopathic effect (CPE); Neutralizing antibody screening; Antiviral drug screening; Immune cell potency assay; Antibody-dependent cell-mediated cytotoxicity (ADCC) assays.
- Application Notes
-
xCELLigence Portfolio Cancer Immunotherapy Handbook
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Application Notes
- English
- 10 Mar 2023
- 10.21 MB
Evaluating Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
- Application Notes
- English
- 03 Jun 2022
- 1.10 MB
A New Way to Monitor Virus-Mediated Cytopathogenicity
This application note describes the experimental setup for assessing vesicular stomatitis virus-mediated cytotoxicity of Vero E6 cells and HEK 293 cells using an xCELLigence instrument.
- Application Notes
- English
- 12 Feb 2021
- 358.59 KB
Label-Free Assay for NK Cell‑Mediated Cytolysis
In this application note, a series of experiments demonstrate how the xCELLigence RTCA system can be applied to quantitatively monitor NK cell‑mediated cytolysis without labeling the target cells.
- Application Notes
- English
- 12 Feb 2021
- 699.12 KB
Vaccine and Virology Applications
A collection of studies showing the benefits of xCELLigence RTCA assays over traditional assays. Antiviral drugs, virucides, neutralizing antibodies and other applications are examined.
- Application Notes
- English
- 02 Jul 2020
- 4.37 MB
Tumor Cell Killing by T Cells
An assay workflow demonstration measuring cytotoxic T lymphocyte-mediated destruction of tumor cells and the corresponding secretion of cytokines using an Agilent xCELLigence and NovoCyte flow cytometer instrument.
- Application Notes
- English
- 02 Jul 2020
- 601.08 KB
- Article Reprints
- Brochures
- Data Sheets
- Flyers
Didn’t find what you need? Contact our dedicated Cell Analysis support teams.
Agilent Cell Analysis Publication Database
Search scientific publications by research area, cell type and more.
Videos
Agilent Wins Scientists’ Choice Award for Best New Drug Discovery & Development Product of 2023
The xCELLigence RTCA HT-BioTek BioSpa 8 integrates label-free, real-time live cell analysis of up to eight 384-well plates with automated incubation. The system expands high-throughput screening capabilities for viral-mediated cytopathic effects (CPE), neutralizing antibodies, antibody-dependent cytotoxicity (ADCC), and compound-mediated cytotoxicity.
- 12 Mar 2024